"What GMO Information has Regulation 2020/10423 withheld?
Under Article 2 of Regulation 2020/1043 any Clinical Trial involving an investigational medicine intended to treat or prevent COVID-19, fromJuly of 2020, was no longer required to submit the GMO [genetically modified organism] information previously required under Part B of Directive 2001/18/EC, (Articles 6 to 11), nor to submit GMO information under Articles 4 to 16 of Directive 2009/41/EC (GMO containment in a lab setting), with the result being for the sponsor(s) of Clinical Trials:
- No need to submit an Environmental Risk Assessment for the GMOs proposed to be used and administered...
- No need to wait for any approval from any authority to handle and administer GMOs...
- No need for any authority to inform or consult with the public before the proposed handling and administration...
- Consequently, no need for sponsors of Clinical Trials to inform participants the investigational medicine to be administered to them, contained GMOs.
- No need to evaluate the risks posed by the GMOs to be administered in a laboratory setting, which is inclusive of Clinical Trials, therefore no evaluation of the Class of risk posed by the GMO was required, nor an assessment of the Level of Containment required by laboratories dealing with GMOs being investigated for COVID-19, therefore not even Biohazard signs were required to be displayed...
Retroposition: The True State of Affairs —mRNAs Do Integrate
... [N]umerous reviews, book chapters on the mRNA vaccines and documents of international organizations... often state that mRNA vaccines do not pose risk for genome integration but do not cite any references in support of this idea...
Domazet-Lošo notes that none of these reviews, chapters, or publications by international organizations, (typically the WHO), ever bothered to reference the established knowledge on the biology of retroposition ... [I]t is beyond question — the field of retroposition studies was well established before Pfizer and Moderna stepped-up with their products...
[P]erhaps more importantly, under the legal definitions applicable in both Europe and Australia, reverse-transcription was not, in and of itself, a necessary precondition for categorising these modRNAs as GMOs.
The fact the LNP-modRNA complex enables entry into a cell (just into the cytoplasm) is sufficient...
Once the Alden et al. paper was published in February 2022, regulators globally should have immediately suspended the modRNA products, admitting these drugs were and are GMOs, and should have started looking for ways to neutralize the modRNA received by billions of people...
But instead of halting the rollout of the GMOs leading to the problems, repeated boosters have been pushed by governments and regulators, so that now our youngest citizens from 6 months old and pregnant mothers are being added to the list of injured victims. They are the ones in whom retroposition mediated genome integration is certain to be most active. The repeated pushing of shots only increases the chances of integration into the human DNA library, altering, indeed, what it means to be human...
When new drugs constructed with the elements of our genes are introduced seemingly out of nowhere, and within months are scaled-up for a global population, told 'everything is fine, just take it, or else' ... the failure to acknowledge over four decades of science speaking to the genetic risks associated with the drugs was never an oversight... The implications are staggering and the canaries in our DNA mine are dying.¨
The author states, "I use the first-person approach here of a lawyer addressing a courtroom with a judge and jury. I realize the style of my presentation is different from what is usually expected in an academic peer-reviewed journal, but I have asked for this liberty in order to drive home key points in the way I plan to hammer them in court."
Copyright (c) 2023 Julian Gillespie
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.